术前夜间右美托咪定输注预防老年髋部骨折术后谵妄的多中心随机双盲试验方案
该方案拟纳入560例65-90岁髋部骨折手术患者,1:1随机接受术前20:00至次日06:00右美托咪定0.2 µg/kg·h或安慰剂输注。主要终点为术后72小时内谵妄发生率,每6小时用3-Minute Diagnostic Confusion Assessment Method评估,采用卡方检验计算相对危险度(95%CI)。
要点
- 评估术前夜间右美托咪定输注能否降低老年髋部骨折术后谵妄发生率
- 主要终点为术后72小时内谵妄发生率,每6小时评估一次
- 若有效,该干预易于纳入常规围手术期护理
核心结论
- 术前夜间右美托咪定输注可能通过改善睡眠质量、减轻神经炎症来降低老年髋部骨折手术患者术后谵妄发生率,尚待本试验验证。
研究设计与样本
- 多中心、随机、双盲、安慰剂对照试验方案,计划纳入560例65-90岁接受髋部骨折手术的患者。
- 参与者按1:1随机分配,术前20:00至次日06:00输注右美托咪定0.2 µg/kg·h或匹配生理盐水。
主要发现
- 既往文献提示术中给予右美托咪定可能减少谵妄,但术前单次夜间输注的获益尚未被评估。
关键数值与推荐
- 主要终点为术后72小时内谵妄发生率,每6小时用3-Minute Diagnostic Confusion Assessment Method评估。
- 相对危险度(95%CI)采用卡方检验计算。
- 次要结局包括谵妄严重程度与持续时间、疼痛评分、睡眠质量、30天和180天认知功能及血浆生物标志物。
临床怎么用
- 若试验证实有效,术前夜间右美托咪定输注可较容易地纳入常规围手术期护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative delirium (POD) is common after hip-fracture surgery in older adults and is associated with prolonged hospitalization, increased mortality, and long-term cognitive decline. Previous literature has indicated that dexmedetomidine may reduce delirium when given intra-operatively; however, the benefit of a single nocturnal infusion before surgery has not been evaluated. We hypothesize that pre-operative night-time dexmedetomidine improves sleep quality and attenuates neuro-inflammation, thereby decreasing POD incidence. METHODS: This multicentre, randomized, double-blind, placebo-controlled trial will enroll 560 patients aged 65-90 years undergoing hip-fracture surgery. Participants will be randomly assigned (1:1) to receive an overnight infusion of dexmedetomidine 0.2 µg/kg·h or matching saline from 20:00 to 06:00 a.m. before surgery. The primary endpoint is the incidence of POD during the first 72 h, assessed every 6 h with the 3-Minute Diagnostic Confusion Assessment Method and the relative risk (95% CI) will be calculated using the chi-square test. Secondary outcomes include delirium severity and duration, pain scores, sleep quality, cognitive function at 30 and 180 days, and plasma biomarkers. DISCUSSION: This protocol evaluates whether the night-before infusion of dexmedetomidine prevents POD in older adults undergoing hip-fracture surgery. If effective, the intervention could easily be implemented in routine peri-operative care. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400087107. Registered on 19 July 2024.
引用
- Song JC, Zhang GP, Ding T, et al. Nocturnal dexmedetomidine infusion versus placebo for prevention of postoperative delirium in elderly patients undergoing hip-fracture surgery: a protocol for a multicentre, randomized, double-blind trial. Trials. 2026. PMID: 41796315. doi:10.1186/s13063-026-09601-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。